×
S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13
S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13
S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13
S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13

NexImmune SEC Filings & 10K Form

$1.72
+0.11 (+6.83%)
(As of 07/1/2022 03:59 PM ET)
Add
Compare
Today's Range
$1.60
$1.76
50-Day Range
$1.61
$3.23
52-Week Range
$1.51
$18.78
Volume
1,430 shs
Average Volume
185,812 shs
Market Capitalization
$39.29 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$8.33

Recent NexImmune SEC Filings

DateFilerForm TypeView
06/17/2022
3:51 PM
NexImmune (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/17/2022
3:49 PM
NexImmune (Filer)
Form 424B5
06/15/2022
4:01 PM
Bertram Timothy (Reporting)
NexImmune (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2022
4:00 PM
D'Angio Paul (Reporting)
NexImmune (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2022
3:59 PM
NexImmune (Issuer)
Roemer Alan S. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2022
3:58 PM
NexImmune (Issuer)
Verstandig Grant (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2022
3:57 PM
BARER SOL J (Reporting)
NexImmune (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2022
3:57 PM
NexImmune (Issuer)
Yao Zhengbin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2022
3:05 PM
NexImmune (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/07/2022
5:17 PM
NexImmune (Issuer)
Verstandig Grant (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/02/2022
6:42 PM
NexImmune (Issuer)
Verstandig Grant (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/02/2022
6:41 PM
BARER SOL J (Reporting)
NexImmune (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/12/2022
3:32 PM
NexImmune (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/12/2022
3:16 PM
NexImmune (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/10/2022
6:43 AM
NexImmune (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/09/2022
5:35 PM
Gandhi Leena (Reporting)
NexImmune (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2022
5:30 PM
Gandhi Leena (Reporting)
NexImmune (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
05/03/2022
3:25 PM
NexImmune (Filer)
Form DEFA14A
04/14/2022
3:17 PM
NexImmune (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/09/2021
3:31 PM
NexImmune (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/09/2021
3:19 PM
NexImmune (Issuer)
Trainer John (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/09/2021
3:06 PM
NexImmune (Issuer)
Trainer John (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/19/2021
3:16 PM
NexImmune (Issuer)
Trainer John (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2021
3:14 PM
NexImmune (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/17/2021
3:10 PM
NexImmune (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/12/2021
3:19 PM
ArrowMark Colorado Holdings LLC (Filed by)
NexImmune (Subject)
Form SC 13G
03/31/2021
4:20 PM
NexImmune (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/31/2021
4:02 PM
Artal International S.C.A. (Filed by)
NexImmune (Subject)
Form SC 13G
03/12/2021
1:00 PM
NexImmune (Issuer)
Trainer John (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/25/2021
4:02 PM
NexImmune (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/19/2021
3:30 PM
Jones Kristi (Reporting)
NexImmune (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2021
3:30 PM
NexImmune (Issuer)
ZELDIS JEROME B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2021
3:26 PM
NexImmune (Issuer)
Roemer Alan S. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2021
3:25 PM
NexImmune (Issuer)
Verstandig Grant (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2021
3:23 PM
D'Angio Paul (Reporting)
NexImmune (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2021
3:20 PM
BARER SOL J (Reporting)
NexImmune (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2021
3:38 PM
NexImmune (Filer)
Form 424B4
02/16/2021
1:57 PM
NexImmune (Issuer)
ZELDIS JEROME B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2021
1:56 PM
NexImmune (Issuer)
Yao Zhengbin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2021
1:55 PM
NexImmune (Issuer)
Verstandig Grant (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2021
1:54 PM
NexImmune (Issuer)
Trainer John (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2021
1:53 PM
NexImmune (Issuer)
Roemer Alan S. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2021
1:51 PM
Knight Robert Douglas (Reporting)
NexImmune (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2021
1:49 PM
Jones Kristi (Reporting)
NexImmune (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2021
1:47 PM
D'Angio Paul (Reporting)
NexImmune (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2021
1:37 PM
Carmer Scott (Reporting)
NexImmune (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2021
1:29 PM
Bertram Timothy (Reporting)
NexImmune (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2021
1:25 PM
BARER SOL J (Reporting)
NexImmune (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/11/2021
11:15 PM
NexImmune (Filer)
Form EFFECT
02/11/2021
8:20 PM
NexImmune (Filer)
Form S-1MEF
02/11/2021
6:30 PM
NexImmune (Issuer)
Verstandig Grant (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
02/11/2021
6:22 PM
NexImmune (Issuer)
ZELDIS JEROME B (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
02/11/2021
6:18 PM
NexImmune (Issuer)
Yao Zhengbin (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
02/11/2021
6:08 PM
NexImmune (Issuer)
Trainer John (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
02/11/2021
6:04 PM
NexImmune (Issuer)
Roemer Alan S. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
02/11/2021
6:01 PM
Knight Robert Douglas (Reporting)
NexImmune (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
02/11/2021
5:59 PM
Jones Kristi (Reporting)
NexImmune (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
02/11/2021
5:54 PM
D'Angio Paul (Reporting)
NexImmune (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
02/11/2021
5:51 PM
Carmer Scott (Reporting)
NexImmune (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
02/11/2021
5:48 PM
Bertram Timothy (Reporting)
NexImmune (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
02/11/2021
5:22 PM
BARER SOL J (Reporting)
NexImmune (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
02/11/2021
7:31 AM
NexImmune (Filer)
Form S-1/A
02/10/2021
2:12 PM
NexImmune (Filer)
Form CERT
02/09/2021
10:58 AM
NexImmune (Filer)
Form 8-A12B
02/08/2021
6:29 AM
NexImmune (Filer)
Form S-1/A
01/19/2021
3:38 PM
NexImmune (Filer)
Form S-1
Registration statement under Securities Act of 1933  
02/22/2019
11:49 AM
NexImmune (Filer)
Form D
Notice of Exempt Offering of Securities 
02/01/2018
1:19 PM
NexImmune (Filer)
Form D
Notice of Exempt Offering of Securities 
This page (NASDAQ:NEXI) was last updated on 7/4/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.